A high level of leucine rich repeats and immunoglobulin like domains 2 (LRIG2) expression, which is linked with GBM progression and poor prognosis, has been shown to increase CD47 expression, and CD47 expression has been shown to be associated with a higher tumor grade and worse clinical outcomes [99,100]. The gene discussed is CD47; the disease is neoplasm.